By assessing the endowment of RAS to isoproterenol-induced cardiac hypertrophy, another study noted that neither the AT1 receptor antagonist nor the ACE inhibitor was able to prevent the β-adrenergic stimulation-induced increase in ventricular weights [125]. This evidence concerns the gene AGTR1 and cardiac hypertrophy.